We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
-9.29%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$24.7B
AUM Growth
-$9.98B
(-29%)
Cap. Flow
-$5.49B
Cap. Flow
% of AUM
-22.2%
Top 10 Holdings %
Top 10 Hldgs %
40.01%
Holding
122
New
16
Increased
31
Reduced
30
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$645M |
| 2 |
Amazon
AMZN
|
+$447M |
| 3 |
International Flavors & Fragrances
IFF
|
+$436M |
| 4 |
XP
XP
|
+$295M |
| 5 |
Otis Worldwide
OTIS
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$1.4B |
| 2 |
Humana
HUM
|
+$1.24B |
| 3 |
Twilio
TWLO
|
+$785M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$659M |
| 5 |
GE Aerospace
GE
|
+$501M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.58% |
| 2 | Financials | 20.43% |
| 3 | Industrials | 13.4% |
| 4 | Technology | 13.29% |
| 5 | Communication Services | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$13.6B
| $289M | 1.17% |
3,752,393
+882,446
| +31% | +$73.8M |
|
27
Thermo Fisher Scientific
TMO
$221B
| $286M | 1.16% |
484,696
+273,638
| +130% | +$157M |
|
|
28
XP
XP
$8.03B
| $284M | 1.15% |
+9,443,312
| New | +$295M |
|
29
Ameriprise Financial
AMP
$49.4B
| $277M | 1.12% |
923,328
-530,468
| -36% | -$160M |
|
|
30
Otis Worldwide
OTIS
$27.8B
| $272M | 1.1% |
+3,538,164
| New | +$283M |
|
31
BridgeBio Pharma
BBIO
$16.3B
| $270M | 1.09% |
26,620,991
| – | – |
|
32
Meta Platforms (Facebook)
META
$1.49T
| $269M | 1.09% |
1,209,602
-676,914
| -36% | -$169M |
|
33
ServiceNow
NOW
$128B
| $245M | 0.99% |
2,202,250
+1,080,945
| +96% | +$121M |
|
|
CTLT
34
DELISTED
CATALENT, INC.
CTLT
| $210M | 0.85% |
1,893,644
+754,290
| +66% | +$78.8M |
|
|
35
Ginkgo Bioworks
DNA
$496M
| $206M | 0.83% |
1,276,379
-7,200,000
| -85% | -$1.4B |
|
36
Tenet Healthcare
THC
$21.1B
| $192M | 0.78% |
2,233,647
-977,594
| -30% | -$80.3M |
|
37
Labcorp
LH
$25.9B
| $192M | 0.78% |
846,562
-143,009
| -14% | -$33.6M |
|
38
Intellia Therapeutics
NTLA
$1.68B
| $179M | 0.73% |
2,468,760
+889,224
| +56% | +$75.3M |
|
39
Global E Online
GLBE
$7.05B
| $173M | 0.7% |
5,128,448
+89,557
| +2% | +$3.38M |
|
40
Deere & Co
DE
$165B
| $167M | 0.68% |
403,163
-530,255
| -57% | -$203M |
|
41
KE Holdings
BEKE
$19.1B
| $166M | 0.67% |
13,440,125
+10,519,869
| +360% | +$187M |
|
42
Rivian
RIVN
$23.3B
| $161M | 0.65% |
3,204,389
| – | – |
|
|
GTM
43
ZoomInfo Technologies
GTM
$1.11B
| $158M | 0.64% |
2,644,137
-62,168
| -2% | -$3.34M |
|
44
Li Auto
LI
$12.3B
| $155M | 0.63% |
6,000,478
+1,514,493
| +34% | +$41.8M |
|
45
Shopify
SHOP
$193B
| $151M | 0.61% |
+2,237,210
| New | +$184M |
|
46
Charles River Laboratories
CRL
$13.6B
| $148M | 0.6% |
521,653
+131,524
| +34% | +$40.6M |
|
47
Insulet
PODD
$9.88B
| $146M | 0.59% |
547,387
-130,807
| -19% | -$32.1M |
|
48
Acadia Healthcare
ACHC
$2.91B
| $140M | 0.56% |
2,130,433
+39,857
| +2% | +$2.32M |
|
49
Molina Healthcare
MOH
$10.5B
| $139M | 0.56% |
416,883
-30,803
| -7% | -$9.48M |
|
50
Zai Lab
ZLAB
$2.85B
| $138M | 0.56% |
3,133,297
+114,339
| +4% | +$5.53M |
|
Similar funds
VIA
Viking Global Investors's Q1 2022 Portfolio in Review
As of Q1 2022, Viking Global Investors held 122 positions worth $24.7B, down 29% from $34.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Viking Global Investors withdrew a net $5.49B in Q1 2022, closing 31 positions and reducing 30 holdings. Its most notable exit was Humana, an estimated $1.24B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 37% a quarter earlier, followed by Financials and Industrials.
Against the trend, Viking Global Investors opened a new position in Mastercard worth $641M.
- Viking Global Investors's largest Q1 2022 buy was Mastercard: 1,793,488 shares worth $641M.
- Viking Global Investors added most to Amazon in Q1 2022, an estimated $447M increase.
- Viking Global Investors's biggest Q1 2022 reduction was Ginkgo Bioworks, cutting an estimated $1.4B.
- Viking Global Investors fully exited Humana in Q1 2022, selling an estimated $1.24B.
- Viking Global Investors's ten largest holdings make up 40% of its $24.7B portfolio in Q1 2022.
- Viking Global Investors opened 16 new positions and closed 31 in Q1 2022.
- Viking Global Investors's portfolio value fell 29% quarter-over-quarter to $24.7B.
Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.